Subscribe today to receive notice of our latest thought leadership, articles, and updates.
Insights
Recent updates
Sharing perspectives leads to greater understanding and fuels innovation
Check out our latest updates:
|
June 13, 2025 · Public Policy & Regulatory Affairs Team
This July 1, 2025, the California DWC will update its pharmacy fees schedule for both large volume and smaller pharmacies, as well as for physician dispensers. This will cover fees for drug ingredients and dispensing of prescribed, OTC, and compounded medications. Read more... |
|
May 28, 2025 · Public Policy & Regulatory Affairs Team
Recent updates from California, Colorado, Louisiana, Michigan, Minnesota, Montana, Oklahoma, Oregon, Tennessee, Vermont, and West Virginia. Read more... |
|
|
May 21, 2025 · Public Policy & Regulatory Affairs Team
In preparation for final implementation of the CMS-1500 project and electronic billing requirements, the New York Workers’ Compensation Board is offering stakeholders several educational seminars. Read more... |
|
May 19, 2025 · Clinical Team
On January 30, 2025, Axsome Therapeutics, Inc. announced the U.S. Food and Drug Administration approval of Symbravo for the acute treatment of migraine with or without aura in adults. Symbravo is not indicated for the prevention of migraine attacks or treatment of cluster headache. Read more... |
|
|
May 08, 2025 · Public Policy & Regulatory Affairs Team
Spring is in full bloom – at least in many states. Updates from Alabama, California, Indiana, Montana, New Mexico, New York, Ohio, Tennessee, and West Virginia Read more... |
|
|
April 15, 2025 · Public Policy & Regulatory Affairs Team
Latest policy updates from Alaska, Colorado, Idaho, Kentucky, Maryland, New Mexico, Ohio, South Dakota, Utah, Virginia, and Wyoming. Read more... |
|
|
April 08, 2025 · Clinical Team
The U.S. Food and Drug Administration (FDA) announced the approval of Journavx™ (suzetrigine) for the treatment of moderate-to-severe acute pain in adults. Read more... |
|
|
April 04, 2025 · Public Policy & Regulatory Affairs Team
A recent ruling by the Pennsylvania Supreme Court changes how some over the counter (OTC) medications are prescribed and provided to injured workers. Read more... |
|
|
March 20, 2025 · Public Policy & Regulatory Affairs Team
Latest policy updates from Alaska, Colorado, Idaho, New Jersey, New York, Oregon, and Virginia, covering fee schedule, presumption, cancer, medical rules, and more. Read more... |
|
|
February 27, 2025 · Public Policy & Regulatory Affairs Team
Latest policy updates from Alabama, Arizona, California, New York, Michigan, Oregon, and Virginia Read more... |
|
|
February 24, 2025 · Public Policy & Regulatory Affairs Team
Besides adopting final rules on its revised workers’ compensation pharmacy fee schedule, the California Division of Workers’ Compensation (DWC) has been busy engaging in public policy development impacting provision of pharmacy and medical care to injured persons in their state. Read more... |
|
|
February 06, 2025 · Public Policy & Regulatory Affairs Team
Latest policy updates from California, Colorado, Florida, Illinois, New Mexico, New York, Ohio, Oklahoma, Oregon, and Virginia Read more... |
Page 1 of 5
